Real-time enrollment status for this aggressive variant prostate carcinoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:53 PM UTC
| NCT Number | NCT07218666 |
| Recruiting Status | Recruiting |
| Condition | Aggressive Variant Prostate Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Deepak Kilari |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 16, 2026: Clinical trial NCT07218666 is currently recruiting participants. This phase2 study for aggressive variant prostate carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Deepak Kilari. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07218666 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07218666 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.